Tag: Coronavirus vaccine

Browse our exclusive articles!

Another nationwide vaccine dry run to be held on Jan 8

Ahead of the roll-out of the coronavirus vaccine in a few days, another dry-run will be conducted across the country on January 8. On January...

Ready to roll out vaccine by Jan 13, says Health Ministry

The Union Health Ministry on Tuesday said that it is prepared to roll out the coronavirus vaccine by January 13, paving way for a...

EU green-lights coronavirus vaccine

The European Union (EU) has approved the usage of the Pfizer/BioNTech vaccine against the novel coronavirus within the bloc, hours after the European Medicines...

India to produce 300mn doses of Sputnik V vaccine in 2021: Report

India will produce about 300 million doses of the Russian Sputnik V coronavirus vaccine in 2021, the head of the Russian Direct Investment Fund...

Vaccinating 130Cr people with injectable Covaxin a challenge: Bharat Biotech

Even as India's first indigenous coronavirus vaccine Covaxin is entering its third phase of human trials, Bharat Biotech on Monday raised the logistical query...

Indian researchers find new mutation in Covid genome for testing

A team of researchers at Nitte University in Karnataka's Mangaluru has identified a new mutation in the Covid-19 genome for testing its virus strain,...

So, Pfizer has a 90% effective vaccine. What happens next?

Stock markets are booming, scientists are hailing Pfizer's vaccine which has shown 90 percent effectiveness and corporates are already imagining the sunny prospect of...

1st batch of Russian vaccine produced for civilian circulation

In some good news for millions living in hope for a Covid-19 vaccine shot, the Russian Health Ministry said on Tuesday that the first...

Pfizer, BioNTech start late stage clinical trial of Covid vax

US-based Pfizer and German biotech firm BioNTech have announced the start of a late-stage clinical trial of a Covid-19 vaccine jointly developed by the...

Moderna begins phase-3 clinical trial of Covid vaccine in US

Pharmaceutical company Moderna has begun a phase-3 clinical trial to evaluate an investigational vaccine known as mRNA-1273 designed to protect against the Covid-19 virus. The...

Popular